118 related articles for article (PubMed ID: 3097674)
1. The additional use of buserelin in HMG-HCG ovulation induction in PCO: a double blind controlled study.
Hompes PG; van Weissenbruch MM; Burger CW; Schoemaker J
Prog Clin Biol Res; 1986; 225():391-9. PubMed ID: 3097674
[No Abstract] [Full Text] [Related]
2. Induction of ovulation in polycystic ovarian disease.
Fleming R
Prog Clin Biol Res; 1986; 225():401-12. PubMed ID: 3097675
[No Abstract] [Full Text] [Related]
3. Induction of ovulation in polycystic ovary: human menopausal gonadotropin or human urinary follicle stimulating hormone?
Venturoli S; Paradisi R; Fabbri R; Porcu E; Orsini LF; Flamigni C
Int J Fertil; 1987; 32(1):66-70. PubMed ID: 2880819
[TBL] [Abstract][Full Text] [Related]
4. Induction of ovulation in the patient with polycystic ovarian disease.
Blankstein J; Quigley MM
Endocrinol Metab Clin North Am; 1988 Dec; 17(4):733-49. PubMed ID: 3143566
[TBL] [Abstract][Full Text] [Related]
5. Ovarian sensitivity to gonadotrophins in patients with PCO is unaffected by suppression of LH.
Fleming R; Hamilton MP; Conaghan C; Black WP; Coutts JR
Clin Endocrinol (Oxf); 1990 Jan; 32(1):33-8. PubMed ID: 2110046
[TBL] [Abstract][Full Text] [Related]
6. [Comparison between purified FSH and hMG for induction of ovulation in women with PCO syndrome].
Uemura T; Yoshimura Y; Ishikawa M; Asukai K; Minaguchi H
Nihon Sanka Fujinka Gakkai Zasshi; 1989 Jul; 41(7):923-6. PubMed ID: 2507714
[No Abstract] [Full Text] [Related]
7. Successful treatment of infertility due to polycystic ovary disease using a combination of luteinising hormone releasing hormone agonist and low dosage menotrophin.
Armitage M; Wilkin T; Dewbury K
Br Med J (Clin Res Ed); 1987 Jul; 295(6590):96. PubMed ID: 3113653
[No Abstract] [Full Text] [Related]
8. [The plasma and urinary hormone profiles during treatment with human gonadotrophins (author's transl)].
Salat-Baroux J; Scemama-Kestenberg H
J Gynecol Obstet Biol Reprod (Paris); 1978; 7(7):1269-90. PubMed ID: 744868
[TBL] [Abstract][Full Text] [Related]
9. Treatment of polycystic ovarian disease by inducing ovulation with pulsatile subcutaneous administration of human menopausal gonadotrophin associated with luteinizing hormone-releasing hormone analogue.
Nakamura Y; Yoshimura Y; Tamaoka Y; Ubukata Y; Yoshida K; Yamada H; Iizuka R; Suzuki M
Clin Endocrinol (Oxf); 1988 Oct; 29(4):395-402. PubMed ID: 3150824
[TBL] [Abstract][Full Text] [Related]
10. The effects of buserelin on the hormonal states in PCOD.
Willemsen WN; Franssen AM; Rolland R; Vemer HM
Prog Clin Biol Res; 1986; 225():377-89. PubMed ID: 3097673
[No Abstract] [Full Text] [Related]
11. Use of LHRH agonists in the treatment of anovulation in women with polycystic ovary syndrome.
Franks S; Sagle M; Mason HD; Kiddy D
Horm Res; 1987; 28(2-4):164-8. PubMed ID: 3136067
[TBL] [Abstract][Full Text] [Related]
12. Combined gonadotropin-releasing hormone analog and exogenous gonadotropins for ovulation induction in infertile women: efficacy related to ovarian function assessment.
Fleming R; Haxton MJ; Hamilton MP; Conaghan CJ; Black WP; Yates RW; Coutts JR
Am J Obstet Gynecol; 1988 Aug; 159(2):376-81. PubMed ID: 3136650
[TBL] [Abstract][Full Text] [Related]
13. Monitoring gonadotropin therapy.
Caldwell BV
J Reprod Med; 1989 Jan; 34(1 Suppl):95-9. PubMed ID: 2497249
[TBL] [Abstract][Full Text] [Related]
14. Comparison between human urinary follicle-stimulating hormone and human menopausal gonadotropin treatment in polycystic ovary.
Venturoli S; Paradisi R; Fabbri R; Magrini O; Porcu E; Flamigni C
Obstet Gynecol; 1984 Jan; 63(1):6-11. PubMed ID: 6419189
[TBL] [Abstract][Full Text] [Related]
15. [Gonadal dysgenesis with secondary amenorrhea unresponsive to HMG-HCG therapy. Case report (author's transl)].
Rosemberg E; Purohit P; Takekida H; Budnitz E
Reproduccion; 1974; 1(1):1-11. PubMed ID: 4464161
[No Abstract] [Full Text] [Related]
16. Hormonal characteristics of follicular fluid from women receiving either GnRH agonist or hCG for ovulation induction.
Andersen CY; Humaidan P; Ejdrup HB; Bungum L; Grøndahl ML; Westergaard LG
Hum Reprod; 2006 Aug; 21(8):2126-30. PubMed ID: 16682403
[TBL] [Abstract][Full Text] [Related]
17. Pharmacologic hypogonadotropism--an advantage for hMG-induced follicular-maturation and succeeding fertilization.
Bettendorf G; Braendle W; Sprotte C; Poels W; Lichtenberg W; Lindner C
Horm Metab Res; 1986 Sep; 18(9):656-7. PubMed ID: 3096863
[No Abstract] [Full Text] [Related]
18. GnRH agonist (buserelin) or hCG for ovulation induction in GnRH antagonist IVF/ICSI cycles: a prospective randomized study.
Humaidan P; Bredkjaer HE; Bungum L; Bungum M; Grøndahl ML; Westergaard L; Andersen CY
Hum Reprod; 2005 May; 20(5):1213-20. PubMed ID: 15760966
[TBL] [Abstract][Full Text] [Related]
19. Ovulation induction in polycystic ovary syndrome with urinary follicle-stimulating hormone or human menopausal gonadotropin.
Seibel MM; McArdle C; Smith D; Taymor ML
Fertil Steril; 1985 May; 43(5):703-8. PubMed ID: 3922800
[TBL] [Abstract][Full Text] [Related]
20. Advances in induction of ovulation.
Franks S; Gilling-Smith C
Curr Opin Obstet Gynecol; 1994 Apr; 6(2):136-40. PubMed ID: 8193252
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
